Cargando…
Altered Metabolic Profiles of the Plasma of Patients with Amyotrophic Lateral Sclerosis
Currently, there is no objective biomarker to indicate disease progression and monitor therapeutic effects for amyotrophic lateral sclerosis (ALS). This study aimed to identify plasma biomarkers for ALS using a targeted metabolomics approach. Plasma levels of 185 metabolites in 36 ALS patients and 3...
Autores principales: | Chang, Kuo-Hsuan, Lin, Chia-Ni, Chen, Chiung-Mei, Lyu, Rong-Kuo, Chu, Chun-Che, Liao, Ming-Feng, Huang, Chin-Chang, Chang, Hong-Shiu, Ro, Long-Sun, Kuo, Hung-Chou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699018/ https://www.ncbi.nlm.nih.gov/pubmed/34944760 http://dx.doi.org/10.3390/biomedicines9121944 |
Ejemplares similares
-
Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients
por: Liao, Ming-Feng, et al.
Publicado: (2014) -
Correlations of clinical, neuroimaging, and electrophysiological features in Hirayama disease
por: Liao, Ming-Feng, et al.
Publicado: (2016) -
Identification of Gene Networks and Pathways Associated with Guillain-Barré Syndrome
por: Chang, Kuo-Hsuan, et al.
Publicado: (2012) -
Clinical Correlations of Motor and Somatosensory Evoked Potentials in Neuromyelitis Optica
por: Tsao, Wei-Chia, et al.
Publicado: (2014) -
Serum levels of cell adhesion molecules in patients with neuromyelitis optica spectrum disorder
por: Chang, Bao‐Luen, et al.
Publicado: (2020)